Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TMO - Repligen: A Niche Play On Biologics


TMO - Repligen: A Niche Play On Biologics

  • Repligen is a investment on the overall growth of the most exciting portion of the biotech industry without exposure to the full risks of the of drug approval process.
  • COVID has a overall effect of increasing demand for Repligen products that helps make the vaccines and therapeutic drugs designed to combat the disease.
  • Repligen's valuation is supported by increased cash flow and profits that are expected to more than double over the next several years.

For further details see:

Repligen: A Niche Play On Biologics
Stock Information

Company Name: Thermo Fisher Scientific Inc
Stock Symbol: TMO
Market: NYSE
Website: corporate.thermofisher.com

Menu

TMO TMO Quote TMO Short TMO News TMO Articles TMO Message Board
Get TMO Alerts

News, Short Squeeze, Breakout and More Instantly...